Author

Xi Chen

Institution: Second Affiliated Hospital of Harbin Medical University

Observed institutions: Northwestern University, Central South University, Xi'an International Studies University, Chinese Academy of Sciences, Cornell University, Zhejiang Cancer Hospital, Second Affiliated Hospital of Harbin Medical University, Shenzhen Institutes of Advanced Technology, Xiangya Hospital Central South University, Weill Cornell Medicine, Hangzhou Institute of Medicine, Chinese Academy of Sciences

ORCID: 0000-0002-6875-7830

Observed ORCID: 0000-0002-6875-7830

OpenAlex ID: A5102676216

EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function

2024 · Yusuke Isshiki, Xi Chen, et al. · Cancer Cell · 75

CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation

2023 · Jing Gao, Zhengyi Wang, et al. · Journal for ImmunoTherapy of Cancer · 53

Progesterone (P4) ameliorates cigarette smoke-induced chronic obstructive pulmonary disease (COPD)

2024 · Bin Xie, Qiong Chen, et al. · Molecular Medicine · 16

Bronchoalveolar Lavage Fluid from Chronic Obstructive Pulmonary Disease Patients Increases Neutrophil Chemotaxis Measured by a Microfluidic Platform

2023 · Jiaqi Ren, Wenfang Chen, et al. · Micromachines · 9

EZH2 Inhibitors Enhance CART Cell Quality, Efficacy, In Vivo Homing, Tumor Cell Binding and Killing of Fully Syngeneic Primary B Cell Lymphomas, As Well As Reprogramming Lymphoma Cells to a Highly Immunogenic and T Cell Adherent Phenotype

2023 · Yusuke Isshiki, Patrizia Porazzi, et al. · Blood · 6

Proactive Power Regulation with Real-time Prediction and Fast Response Guardband for Fine-grained Dynamic Voltage Droop Mitigation on Digital SoCs

2023 · Xi Chen, Jiaxiang Feng, et al. · IEEE Symposium on VLSI Technology and Circuits (VLSI Technology and Circuits) · 6

A Novel Disulfidptosis-related lncRNAs Prognostic Signature for Prognosis Predicting and Immune Microenvironment Characterization in Breast Cancer

2024 · Xi Chen, Chen Yang · Current Medicinal Chemistry · 3

Clinically friendly smart hydrogel boosts cuproptosis and PD-L1 upregulation to enhance anti-tumor immunotherapy

2025 · Baiyang Fu, Guangyan Li, et al. · Materials Today Bio · 1

Spatial Multi-Omics Treatment Paradigms in a Phase II Clinical Study of Early Relapsed/Refractory Diffuse Large B-Cell Lymphoma

2024 · Meijuan Wu, Xi Chen, et al. · Blood · 1

965 A novel bi-paratopic ROR1×4–1BB tri-specific antibody for enhanced anti-tumor immunity through tumor-localized 4–1BB agonist activity

2025 · Chanjuan Liu, Xiaojun Xing, et al. · Regular and Young Investigator Award Abstracts

Abstract PR01: EZH2 inhibitors improve CAR-T therapy by enhancing lymphoma B cell immunogenicity and CAR-T cell functions

2024 · Yusuke Isshiki, Xi Chen, et al. · Blood Cancer Discovery

A deep learning-based approach to classroom concentration analysis

2023 · Lu Li, Xi Chen, et al. · International Conference on Artificial Intelligence and Electromechanical Automation (AIEA)

Works count: 12

Citation count: 170

H-index: 6

I10-index: 3